Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Upgrade
Fly Intel: Top five analyst upgrades » 09:55
09/10/21
09/10
09:55
09/10/21
09:55
HBM

Hudbay Minerals

$6.35 /

+0.46 (+7.81%)

, ALLE

Allegion

$146.76 /

+3.45 (+2.41%)

, RXN

Rexnord

$64.02 /

+1.15 (+1.83%)

, CNO

CNO Financial

$23.91 /

+0.645 (+2.77%)

, EDIT

Editas Medicine

$66.60 /

+2.01 (+3.11%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Hudbay Minerals (HBM) upgraded to Outperform from Sector Perform at National Bank with analyst Shane Nagle saying the shares have declined 17% year-to-data on heightened political risks in Peru, but political risks will subside. 2. Allegion (ALLE) upgraded to Buy from Neutral at Goldman Sachs with analyst Joe Ritchie saying Allegion is a late cycle, non-residential manufacturer that is exposed to the "favorable thematic backdrop" of education stimulus. 3. Rexnord (RXN) upgraded to Buy from Neutral at Goldman Sachs with analyst Joe Ritchie saying Rexnord is a "high quality, water-levered story" with favorable non-residential exposure. 4. CNO Financial (CNO) upgraded to Overweight from Neutral at Piper Sandler with analyst John Barnidge thinking CNO will outperform the broader life insurance group over the next several quarters. 5. Editas Medicine (EDIT) upgraded to Outperform from Perform at Oppenheimer with analyst Jay Olson saying that he looks forward to EDIT-101 clinical results in LCA10, including safety data and preliminary efficacy endpoints, from low-dose and mid-dose cohorts at RD2021 this month, representing the first clinical data reported by Editas, and believes the cell medicine franchise and in vivo programs beyond ophthalmology offer upside in the longer term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
RXN Rexnord
$64.02 /

+1.15 (+1.83%)

HBM Hudbay Minerals
$6.35 /

+0.46 (+7.81%)

EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

CNO CNO Financial
$23.91 /

+0.645 (+2.77%)

ALLE Allegion
$146.76 /

+3.45 (+2.41%)

HBM Hudbay Minerals
$6.35 /

+0.46 (+7.81%)

09/10/21 National Bank
Hudbay Minerals upgraded to Outperform from Sector Perform at National Bank
08/25/21 Credit Suisse
Hudbay Minerals price target lowered to C$11.50 from C$13 at Credit Suisse
07/19/21 Credit Suisse
Hudbay Minerals price target lowered to C$13 from C$14 at Credit Suisse
07/16/21 National Bank
Hudbay Minerals price target raised to C$14 from C$13 at National Bank
ALLE Allegion
$146.76 /

+3.45 (+2.41%)

09/10/21 Goldman Sachs
Allegion upgraded to Buy from Neutral at Goldman Sachs
07/23/21 Barclays
Allegion price target raised to EUR 176 from EUR 165 at Barclays
04/06/21
Fly Intel: Top five analyst upgrades
04/06/21 Barclays
Allegion upgraded to Overweight from Underweight at Barclays
RXN Rexnord
$64.02 /

+1.15 (+1.83%)

09/10/21 Goldman Sachs
Rexnord upgraded to Buy from Neutral at Goldman Sachs
09/08/21 KeyBanc
Rexnord price target raised to $72 from $60 at KeyBanc
09/08/21 KeyBanc
Regal Beloit price target raised to $185 from $175 at KeyBanc
08/06/21 Baird
Rexnord price target raised to $70 from $66 at Baird
CNO CNO Financial
$23.91 /

+0.645 (+2.77%)

09/10/21 Piper Sandler
CNO Financial upgraded to Overweight from Neutral at Piper Sandler
07/08/21 Piper Sandler
CNO Financial price target lowered to $25 from $28 at Piper Sandler
03/31/21 Citi
CNO Financial price target raised to $25 from $23 at Citi
03/31/21 Piper Sandler
CNO Financial downgraded to Neutral from Overweight at Piper Sandler
EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

09/10/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
09/09/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
08/09/21
Fly Intel: Top five analyst upgrades
08/09/21 Truist
Editas Medicine upgraded to Buy from Hold at Truist
RXN Rexnord
$64.02 /

+1.15 (+1.83%)

HBM Hudbay Minerals
$6.35 /

+0.46 (+7.81%)

EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

CNO CNO Financial
$23.91 /

+0.645 (+2.77%)

ALLE Allegion
$146.76 /

+3.45 (+2.41%)

  • 21
    Jan
RXN Rexnord
$64.02 /

+1.15 (+1.83%)

EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

ALLE Allegion
$146.76 /

+3.45 (+2.41%)

Upgrade
Allegion upgraded to Buy from Neutral at Goldman Sachs » 04:50
09/10/21
09/10
04:50
09/10/21
04:50
ALLE

Allegion

$143.34 /

-1.51 (-1.04%)

Goldman Sachs analyst Joe…

Goldman Sachs analyst Joe Ritchie upgraded Allegion to Buy from Neutral with a price target of $174, up from $158, implying 20% upside from current levels. Allegion is a late cycle, non-residential manufacturer that is exposed to the "favorable thematic backdrop" of education stimulus, Ritchie tells investors in a research note. The analyst believes the company is "well poised to compound value over time" as its line growth is complemented with improving mix and fading temporary cost headwinds.

ShowHide Related Items >><<
ALLE Allegion
$143.34 /

-1.51 (-1.04%)

ALLE Allegion
$143.34 /

-1.51 (-1.04%)

07/23/21 Barclays
Allegion price target raised to EUR 176 from EUR 165 at Barclays
04/06/21
Fly Intel: Top five analyst upgrades
04/06/21 Barclays
Allegion upgraded to Overweight from Underweight at Barclays
03/16/21 Longbow
Allegion upgraded to Buy from Neutral at Longbow
ALLE Allegion
$143.34 /

-1.51 (-1.04%)

ALLE Allegion
$143.34 /

-1.51 (-1.04%)

Over a month ago
Hot Stocks
Allegion acquires European software companies, terms undisclosed » 07:29
07/29/21
07/29
07:29
07/29/21
07:29
ALLE

Allegion

$135.61 /

-1.07 (-0.78%)

Allegion has acquired,…

Allegion has acquired, through its subsidiaries, certain assets of Astrum Benelux B.V. as well as privately held WorkforceIT B.V. Astrum Benelux B.V. and WorkforceIT B.V. are workforce management technology companies in the Benelux region of Europe. Astrum Benelux B.V. is a long-standing sales, distribution and development partner for both Allegion and its European workforce management brand, Interflex. Astrum Benelux B.V. and WorkforceIT B.V. serve as authorized Benelux region resellers of Interflex's SP-EXPERT software, a modern and flexible advanced workforce management solution that allows users to schedule and deploy employees to the right place at the right time.

ShowHide Related Items >><<
ALLE Allegion
$135.61 /

-1.07 (-0.78%)

ALLE Allegion
$135.61 /

-1.07 (-0.78%)

07/23/21 Barclays
Allegion price target raised to EUR 176 from EUR 165 at Barclays
04/06/21
Fly Intel: Top five analyst upgrades
04/06/21 Barclays
Allegion upgraded to Overweight from Underweight at Barclays
03/16/21 Longbow
Allegion upgraded to Buy from Neutral at Longbow
ALLE Allegion
$135.61 /

-1.07 (-0.78%)

ALLE Allegion
$135.61 /

-1.07 (-0.78%)

Recommendations
Allegion price target raised to EUR 176 from EUR 165 at Barclays » 11:14
07/23/21
07/23
11:14
07/23/21
11:14
ALLE

Allegion

$138.20 /

+2.28 (+1.68%)

Barclays analyst Julian…

Barclays analyst Julian Mitchell raised the firm's price target on Allegion to EUR 176 from EUR 165 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
ALLE Allegion
$138.20 /

+2.28 (+1.68%)

ALLE Allegion
$138.20 /

+2.28 (+1.68%)

04/06/21
Fly Intel: Top five analyst upgrades
04/06/21 Barclays
Allegion upgraded to Overweight from Underweight at Barclays
03/16/21 Longbow
Allegion upgraded to Buy from Neutral at Longbow
02/22/21 Barclays
Allegion price target raised to $107 from $105 at Barclays
ALLE Allegion
$138.20 /

+2.28 (+1.68%)

ALLE Allegion
$138.20 /

+2.28 (+1.68%)

Earnings
Allegion raises FY21 adjusted EPS view to $5.25-$5.40 from $5.00-$5.15 » 05:35
07/22/21
07/22
05:35
07/22/21
05:35
ALLE

Allegion

$140.70 /

-0.735 (-0.52%)

Consensus $5.24. Raises…

Consensus $5.24. Raises FY21 revenue view to up 7%-7.5% from up 3%-4%, consensus $2.86B. Adjustments to 2021 EPS include estimated impacts of 10c per share for restructuring and acquisition and integration expenses. The outlook includes incremental investment of approximately 20c per share; assumes a full-year adjusted effective tax rate of approximately 12% and assumes an average diluted share count for the full year of approximately 91M shares. The company is also raising its outlook for full-year available cash flow to approximately $490M to $510M. "Global macroeconomic indicators and construction indices continue to be positive, and demand has rebounded faster than anticipated," Petratis added. "This heightened demand has led to global supply chain pressures that will temper the pace of recovery for the remainder of the year. We have stepped up our strategic investments and partnerships and believe those actions, paired with our demonstrated abilities in supply chain management, position us well to emerge from the pandemic strong as the market migrates to seamless access solutions."

ShowHide Related Items >><<
ALLE Allegion
$140.70 /

-0.735 (-0.52%)

ALLE Allegion
$140.70 /

-0.735 (-0.52%)

04/06/21
Fly Intel: Top five analyst upgrades
04/06/21 Barclays
Allegion upgraded to Overweight from Underweight at Barclays
03/16/21 Longbow
Allegion upgraded to Buy from Neutral at Longbow
02/22/21 Barclays
Allegion price target raised to $107 from $105 at Barclays
ALLE Allegion
$140.70 /

-0.735 (-0.52%)

ALLE Allegion
$140.70 /

-0.735 (-0.52%)

Earnings
Allegion reports Q2 adjusted EPS $1.32, consensus $1.29 » 05:32
07/22/21
07/22
05:32
07/22/21
05:32
ALLE

Allegion

$140.70 /

-0.735 (-0.52%)

Reports Q2 revenue…

Reports Q2 revenue $746.9M, consensus $708.47M. "I'm encouraged by the robust customer demand and solid results delivered by our business in the second quarter," said David Petratis, Allegion chairman, president and CEO. "We continue to see the benefits of the newly formed Allegion International reporting segment, including Q2 growth in the core business, strong execution and focus. Our Allegion Americas business experienced continued strength in residential, and non-residential returned to growth, driven by retrofit, repair and small projects. I'm also pleased with the growth in electronics and the margin expansion our company delivered against macroeconomic challenges like increased commodity, freight and labor inflation, as well as shortages in parts and labor."

ShowHide Related Items >><<
ALLE Allegion
$140.70 /

-0.735 (-0.52%)

ALLE Allegion
$140.70 /

-0.735 (-0.52%)

04/06/21
Fly Intel: Top five analyst upgrades
04/06/21 Barclays
Allegion upgraded to Overweight from Underweight at Barclays
03/16/21 Longbow
Allegion upgraded to Buy from Neutral at Longbow
02/22/21 Barclays
Allegion price target raised to $107 from $105 at Barclays
ALLE Allegion
$140.70 /

-0.735 (-0.52%)

ALLE Allegion
$140.70 /

-0.735 (-0.52%)

Over a quarter ago
Earnings
Allegion raises FY21 adjusted EPS view to $5.00-$5.15 from $4.70-$4.85 » 06:17
04/22/21
04/22
06:17
04/22/21
06:17
ALLE

Allegion

$133.16 /

+0.915 (+0.69%)

Consensus $4.89. The…

Consensus $4.89. The company is also raising its FY21 revenue outlook and now expects reported revenue to increase 3%-4% and organic revenue to be up 2% to 3%, when compared with 2020, after excluding the expected impacts of acquisitions, divestitures and foreign currency movements. The company is also raising its outlook for full-year available cash flow to approximately $430M to $450M from $400M-$420M. CEO David Petratis says: "Global macroeconomic indicators and construction indices continue to improve, and I am increasingly optimistic on the economic recovery. The fundamentals of the business are strong, with demand improving throughout the quarter. Although we expect ongoing supply chain and inflationary pressures, we are confident we can continue to meet improving customer demand. Our strategic investments are serving us well and, we believe, will position us to emerge strong as the market migrates to seamless access solutions and as commercial and institutional projects move forward."

ShowHide Related Items >><<
ALLE Allegion
$133.16 /

+0.915 (+0.69%)

ALLE Allegion
$133.16 /

+0.915 (+0.69%)

04/06/21
Fly Intel: Top five analyst upgrades
04/06/21 Barclays
Allegion upgraded to Overweight from Underweight at Barclays
03/16/21 Longbow
Allegion upgraded to Buy from Neutral at Longbow
02/22/21 Barclays
Allegion price target raised to $107 from $105 at Barclays
ALLE Allegion
$133.16 /

+0.915 (+0.69%)

ALLE Allegion
$133.16 /

+0.915 (+0.69%)

Earnings
Allegion reports Q1 adjusted EPS $1.20, consensus $1.02 » 06:15
04/22/21
04/22
06:15
04/22/21
06:15
ALLE

Allegion

$133.16 /

+0.915 (+0.69%)

Reports Q1 revenue…

Reports Q1 revenue $694.3M, consensus $649.76M. "Allegion is off to a great start in 2021. We delivered solid top-line growth and margin expansion against a tough comparable from the first quarter of last year," said David D. Petratis, Allegion chairman, president and CEO. "The Allegion International business has continued to rebound and meet increased demand, while the Americas residential business remained strong. I am also pleased with the margin expansion delivered as cost reduction and mitigation actions taken last year continue to provide benefits."

ShowHide Related Items >><<
ALLE Allegion
$133.16 /

+0.915 (+0.69%)

ALLE Allegion
$133.16 /

+0.915 (+0.69%)

04/06/21
Fly Intel: Top five analyst upgrades
04/06/21 Barclays
Allegion upgraded to Overweight from Underweight at Barclays
03/16/21 Longbow
Allegion upgraded to Buy from Neutral at Longbow
02/22/21 Barclays
Allegion price target raised to $107 from $105 at Barclays
ALLE Allegion
$133.16 /

+0.915 (+0.69%)

ALLE Allegion
$133.16 /

+0.915 (+0.69%)

Syndicate
Allegion files automatic mixed securities shelf  16:34
04/14/21
04/14
16:34
04/14/21
16:34
ALLE

Allegion

$130.20 /

+0.9 (+0.70%)

 
ShowHide Related Items >><<
ALLE Allegion
$130.20 /

+0.9 (+0.70%)

ALLE Allegion
$130.20 /

+0.9 (+0.70%)

04/06/21
Fly Intel: Top five analyst upgrades
04/06/21 Barclays
Allegion upgraded to Overweight from Underweight at Barclays
03/16/21 Longbow
Allegion upgraded to Buy from Neutral at Longbow
02/22/21 Barclays
Allegion price target raised to $107 from $105 at Barclays
ALLE Allegion
$130.20 /

+0.9 (+0.70%)

ALLE Allegion
$130.20 /

+0.9 (+0.70%)

Upgrade
Fly Intel: Top five analyst upgrades » 09:53
04/06/21
04/06
09:53
04/06/21
09:53
WYNN

Wynn Resorts

$133.71 /

+2.54 (+1.94%)

, ALLE

Allegion

$133.13 /

+3.18 (+2.45%)

, HBM

Hudbay Minerals

$8.09 /

+0.47 (+6.17%)

, PARR

Par Pacific

$16.33 /

+1.52 (+10.26%)

, UAL

United Airlines

$59.60 /

+0.3 (+0.51%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wynn Resorts (WYNN) upgraded to Buy from Hold at Argus with analyst John Staszak saying the upgrade reflects the recovery in the company's Las Vegas business and growth in its Boston operations as more COVID vaccines are rolled out and leisure travel returns. 2. Allegion (ALLE) double upgraded to Overweight from Underweight saying Allegion's risk/reward "looks significantly more attractive today versus many other names in our sector." 3. Hudbay Minerals (HBM) upgraded to Buy from Underperform at BofA with analyst Lawson Winder citing the company's announcement of improved life of mine plans for its Snow Lake and Constancia mines, the "encouraging" initial drill properties in Arizona, and the copper growth optionality from the more recently identified Constancia satellite monetization and the Mason project in Nevada. 4. Par Pacific (PARR) upgraded to Buy from Neutral at Goldman Sachs with analyst Neil Mehta saying he has a "constructive view" on the oil demand recovery in the medium term. 5. United Airlines (UAL) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Ravi Shanker saying given his contention that 2022 consensus numbers are too low for the U.S. Airlines group given his view of strong volume and cost tailwinds. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
WYNN Wynn Resorts
$133.71 /

+2.54 (+1.94%)

UAL United Airlines
$59.60 /

+0.3 (+0.51%)

PARR Par Pacific
$16.33 /

+1.52 (+10.26%)

HBM Hudbay Minerals
$8.09 /

+0.47 (+6.17%)

ALLE Allegion
$133.13 /

+3.18 (+2.45%)

WYNN Wynn Resorts
$133.71 /

+2.54 (+1.94%)

04/06/21 Argus
Wynn Resorts upgraded to Buy from Hold at Argus
04/06/21 Argus
Wynn Resorts upgraded to Buy from Hold at Argus
04/05/21 Morgan Stanley
Caesars upgraded to Overweight from Equal Weight at Morgan Stanley
03/29/21 Deutsche Bank
New York may be 'kicking the can' on sports betting, says Deutsche
ALLE Allegion
$133.13 /

+3.18 (+2.45%)

04/06/21 Barclays
Allegion upgraded to Overweight from Underweight at Barclays
03/16/21 Longbow
Allegion upgraded to Buy from Neutral at Longbow
02/22/21 Barclays
Allegion price target raised to $107 from $105 at Barclays
11/11/20 BofA
Allegion upgraded to Buy on 'catch up' expectations at BofA
HBM Hudbay Minerals
$8.09 /

+0.47 (+6.17%)

04/06/21 Raymond James
Hudbay Minerals upgraded to Outperform from Market Perform at Raymond James
04/06/21 BofA
Hudbay Minerals upgraded to Buy from Underperform at BofA
04/06/21 BofA
Hudbay Minerals upgraded to Buy from Underperform at BofA
03/31/21 Canaccord
Hudbay Minerals price target lowered to C$11 from C$12 at Canaccord
PARR Par Pacific
$16.33 /

+1.52 (+10.26%)

04/06/21 Goldman Sachs
Par Pacific upgraded to Buy from Neutral at Goldman Sachs
04/01/21 Piper Sandler
Par Pacific price target raised to $14 from $11 at Piper Sandler
03/01/21 Cowen
Par Pacific upgraded to Outperform from Market Perform at Cowen
02/22/21 JPMorgan
Par Pacific upgraded to Neutral on valuation at JPMorgan
UAL United Airlines
$59.60 /

+0.3 (+0.51%)

04/06/21 Morgan Stanley
Morgan Stanley sees further airline upside, upgrades United and Alaska Air
04/06/21 Morgan Stanley
United Airlines upgraded to Equal Weight from Underweight at Morgan Stanley
03/30/21 Jefferies
United Airlines price target raised to $60 from $55 at Jefferies
03/16/21 Goldman Sachs
United Airlines price target raised to $74 from $54 at Goldman Sachs
WYNN Wynn Resorts
$133.71 /

+2.54 (+1.94%)

UAL United Airlines
$59.60 /

+0.3 (+0.51%)

PARR Par Pacific
$16.33 /

+1.52 (+10.26%)

HBM Hudbay Minerals
$8.09 /

+0.47 (+6.17%)

ALLE Allegion
$133.13 /

+3.18 (+2.45%)

  • 17
    Mar
  • 09
    Feb
  • 22
    Apr
WYNN Wynn Resorts
$133.71 /

+2.54 (+1.94%)

UAL United Airlines
$59.60 /

+0.3 (+0.51%)

WYNN Wynn Resorts
$133.71 /

+2.54 (+1.94%)

UAL United Airlines
$59.60 /

+0.3 (+0.51%)

WYNN Wynn Resorts
$133.71 /

+2.54 (+1.94%)

UAL United Airlines
$59.60 /

+0.3 (+0.51%)

PARR Par Pacific
$16.33 /

+1.52 (+10.26%)

ALLE Allegion
$133.13 /

+3.18 (+2.45%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.